Physician

Adwait H Jathal, M.D.

According to 2025 Medicare claims, Adwait Jathal, M.D. (NPI: 1972574333) practices gastroenterology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is MEDICAL ASSOCIATES OF BREVARD LLC (NPI: 1861400103; TIN: 593360315) and primary practice location at 32901-3179. Jathal is affiliated with the Aledade A2909 FL MSSP Enhanced (ACO ID: A2909), participating under the MSSP model.

Jathal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 526 traditional Medicare patients, billed 872 HCPCS/CPT codes, and received $90,953 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 988 prescription claims across 523 beneficiaries totaling $252,601 in drug costs, led by Creon (Lipase/Protease/Amylase). Open Payments data shows 59 records totaling $900. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,163,453 to $252,601. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	616	1,223	$129,786
2016	608	1,192	$127,014
2017	626	1,284	$135,119
2018	641	1,382	$136,656
2019	653	1,354	$146,688
2020	522	1,019	$106,942
2021	511	983	$110,666
2022	554	996	$121,949
2023	533	1,043	$116,419
2024	526	872	$90,953

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	193	634	$1,163,453
2016	234	580	$507,883
2017	395	861	$272,350
2018	380	825	$333,551
2019	479	989	$395,717
2020	449	990	$514,947
2021	490	1,020	$290,617
2022	458	1,000	$285,895
2023	491	1,003	$327,401
2024	523	988	$252,601

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	119	119	$166
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	87	87	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	97	113	$87
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	164	164	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	135	143	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	13	438	$23,343
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	305	408	$19,052
Clenpiq	Sod Picosulf/Mag Ox/Citric Ac	37	75	$6,342
Mesalamine	Mesalamine	16	1,036	$5,092
Ursodiol	Ursodiol	18	1,240	$3,853

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	59	$900	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adwait H. Jathal, M.D.?

Tedicare shows public-source Medicare data for Adwait H. Jathal, M.D. (NPI 1972574333), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adwait H. Jathal, M.D. have ACO affiliation data?

Adwait H. Jathal, M.D. is shown with ACO affiliation data for Aledade A2909 FL MSSP Enhanced (MSSP, ACO ID A2909).

What billing organization is linked to Adwait H. Jathal, M.D.?

Adwait H. Jathal, M.D. is linked to MEDICAL ASSOCIATES OF BREVARD LLC (billing NPI 1861400103) in the available physician profile data.

Does Adwait H. Jathal, M.D. have Open Payments data?

Adwait H. Jathal, M.D. has 59 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.